Article Information
History
- March 26, 2021.
Article Versions
- You are currently viewing Version 1 of this article (March 26, 2021 - 12:36).
- View Version 2, the most recent version of this article.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY 4.0 International license.
Author Information
- Johanna Huoman, PhD1,†,
- David Martínez-Enguita, MSc2,
- Elin Olsson, MSc2,
- Jan Ernerudh, MD PhD3,
- Lennart Nilsson, MD PhD4,
- Karel Duchén, MD PhD4,
- Mika Gustafsson, PhD2,* and
- Maria C Jenmalm, PhD1,*
- 1Division of Inflammation and Infection, Department of Biomedical and Clinical Sciences, Linköping University, Linköping, Sweden
- 2Department of Physics, Chemistry and Biology, Linköping University, Linköping, Sweden
- 3Department of Clinical Immunology and Transfusion Medicine, Department of Biomedical and Clinical Sciences, Linköping University, Linköping, Sweden
- 4Allergy Center, Department of Biomedical and Clinical Sciences, Linköping University, Linköping, Sweden
- ↵†Corresponding author:
Johanna Huoman, PhD, Division of Inflammation and Infection, Department of Biomedical and Clinical Sciences, Faculty of Medicine and Health Sciences, Linköping University, Lab 1, Building 420, entrance 68, level 12, 581 83 Linköping, Sweden, E-mail: johanna.huoman{at}liu.se, Phone: +46 76 069 63 38